植物化学品作为癌症治疗中的铁灭调节剂的新兴趋势
Fahad Khan1, Pratibha Pandey1, Meenakshi Verma2
1Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
概括
细胞死亡过程 - - 铁亡对于抑制癌症至关重要. 自然化合物可以诱导癌细胞中的铁亡,提供新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 铁亡是一种受调节的细胞死亡途径,依赖于铁和脂质过氧化.
- 这种细胞死亡机制与各种疾病有关,包括癌症,神经系统疾病和心血管疾病.
- 诱导癌细胞中的铁亡是抑制瘤进展和扩散的关键策略.
研究的目的:
- 审查最近铁灭的分子机制的进展.
- 为了突出铁死在癌症治疗中的意义.
- 总结自然植物化学物质在诱导铁亡中的作用,用于抗癌药物开发.
主要方法:
- 关于铁亡及其在癌症中的作用的当前文献的综述.
- 分析涉及自然化合物诱导铁灭的分子途径.
- 检查天然产品作为诱导铁亡的抗癌剂的潜力.
主要成果:
- 铁症可以由合成化合物和天然生物活性物质触发.
- 天然产品为癌症治疗提供了一个有前途的途径,因为它们具有多个目标效果和最小的副作用.
- 植物化学物质可以通过活性氧物种 (ROS) 生产和ferritinophagy诱导ferroptosis.
结论:
- 铁化是新型抗癌疗法的关键标.
- 天然植物化学物质在诱导铁亡和治疗恶性瘤方面具有显著的潜力.
- 对与铁死相关的自然化合物的进一步研究可能会导致新的抗癌药物的开发.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


